Clinical Outcomes of Cagrilintide and GLP-1 (S) in Obesity
The tradeoff: tirzepatide is newer with less long-term safety data than semaglutide, though its profile to date looks equally favorable
So these GLP-1s basically mimic a hormone in the body that controls insulin and blood glucose levels, which can make a patient feel less hungry or feel full for longer
However, most studies of pancreatic mass or exocrine cellular proliferation have reported no change with exenatide, liraglutide, or dulaglutide (86, 108, 109, 119, 121)
USA TODAY Shopping will be covering all the best deals and drops so be sure to sign up for text alerts, check us out on Flipboard, follow us on TikTok, sign up for our newsletter and follow us on Instagram to stay updated!
the quotes from our CEO and SVP, Weight Management